Crinetics Pharmaceuticals, Inc. Expense Breakdown
No Expense Breakdown for CRNX on this site yet.
- 2026-06-30: Reportable $154.00K.
- 2025-06-30: Reportable $0.00.
Source checked: the stored Expense Breakdown page for CRNX.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $154.00K |
|---|
| 2025-06-30 | $0.00 |
|---|
Research and development: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $99.85M |
|---|
| 2025-06-30 | $80.30M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $57.57M |
|---|
| 2025-06-30 | $49.84M |
|---|